Pharmaceutical Contract Packaging Market

The global pharmaceutical contract packaging market offers significant growth prospects for several small and medium scale companies. The industry is characterized by the presence of local companies operating with significant profit margins. The pharmaceutical contract packaging market study provides analysis of primary packaging, secondary packaging, and tertiary packaging. Further, the primary packaging is further analyzed across Bottles, Vials, Ampoules, Blister Packs, and Others. In addition, different materials used in pharmaceutical contract packaging market including glass, plastics, polymers, paper and paperboard, metals, and others present robust market outlook. Further, pharmaceutical contract packaging market size is forecast across 25 countries. In addition, 10 leading companies are also profiled in the report.

 

Pharmaceutical Contract Packaging Market Study Highlights, 2023

• The global Pharmaceutical Contract Packaging Market Size stood at $26.9 Billion in 2022 and is poised to register 7.43% growth over the forecast period from 2023 to 2030
• Primary-type Pharmaceutical Contract Packaging is the largest type with 44.1% market share. Other packaging types include secondary and tertiary types of Pharmaceutical Contract Packaging.  
• The primary packaging is further sub-segmented into Bottles, Vials, Ampoules, Blister Packs, and Others. Of these, bottles held the dominant share within primary packaging with the highest market share.
• Among materials used for packaging, glass remains the dominant material in Pharmaceutical Contract Packaging in value terms, with a market share of 34% in 2022. Other material types include Plastics and Polymers, Paper and Paperboard, Metals, and Others
• Driven by the US, North America dominates the global Pharmaceutical Contract Packaging market with a dominant market share
• Increasing demand for sustainable packaging, adherence to stringent regulatory standards across countries, demand for parenteral containers, the evolution of advanced technologies including nanotechnology, growth in the geriatric population, and increasing global healthcare expenditure worldwide are among the main market dynamics
• On the other hand, the need for increased investments in R&D, stringent government regulations, and fragmented market conditions pose challenges to market growth
• The market is highly competitive with intense competitive conditions among leading market players.

 

Pharmaceutical Contract Packaging Market Outlook to 2030

Pharmaceutical Contract Packaging Market Overview

The growing supply and demand of pharmaceutical drugs are encouraging the demand for a vast range of primary packaging services that meet the needs of the pharmaceutical industry. Pharmaceutical contract packaging involving the outsourcing of operations like drug packaging and labeling to third parties enables cost and time saving for companies. Contract packaging provides the flexibility of handling volume of a diverse range- from short runs to high-volume, commercial-scale production.

Amidst rapid market demand for pharmaceutical packaging from third parties, several small and medium-scale companies are foraying into the industry. As rapid, multi-country launches are widely observed, companies with a deep understanding of global regulatory and compliance challenges tend to gain significant market penetration.

The growing number of virtual pharmaceutical companies, demand from emerging markets, the drive towards the focus on maximizing internal resources, and others are encouraging business for contract packaging. 

Third-party companies are investing significantly in the latest market and technology trends to gain business in the increasingly competitive industry. Patient-friendly and innovative packaging are among the key parameters marketed by leading companies. In addition, efficient and integral package design, experience with various types of materials, quick turnaround times, flexibility, and maximum yield are also marketed.

Wide range of customer base including Branded pharmaceuticals, Specialty pharmaceuticals, Orphan Drugs, Retail Pharmacies, Over-The-Counter (OTC) medications, Generic drugs, and Private label pharmaceuticals rely on contract packaging

Establishing partnerships with larger CMOs is also identified as a key strategy for small and medium-scale companies. As small requirements sometimes cannot be justified in terms of line clearance and changeover times, large players also tend to outsource their projects to small and medium-scale packaging companies.

The ongoing research on packaging materials, development of new technologies to address complex designs, and focus on lowering overall costs are set to shape the future of the Pharmaceutical Contract Packaging industry.

Key companies operating in the industry include- Ropack Inc., UDG Healthcare Plc., Reed-Lane, Inc., AbbVie Contract Manufacturing, PCI Pharma Services, UNICEP Packaging LLC, Ball Corp, Amcor Plc, Daito Pharmaceutical, Patheon Pharma Services, and others.

 

Pharmaceutical Contract Packaging Market Trend - Evolution of advanced technologies including nanotechnology

To attract a wide range of clients, large contract organizations are building up their manufacturing capabilities. The adoption of new technologies including artificial intelligence, minimal human intervention, smart manufacturing, and others is widely observed.

In addition, nanotechnology is being used as part of authentication and anti-counterfeiting technologies in pharmaceutical packaging applications. To prevent counterfeit drugs, the use of nanotechnology is likely to play a major role in pharmaceutical packaging in the future.

 

Pharmaceutical Contract Packaging Market Drivers- Increasing demand for sustainable packaging

The drive towards the use of biodegradable and sustainable plastic alternatives in pharmaceutical packaging is widely observed across industries. The $1.3 trillion pharmaceutical industry is rapidly opting for lowering plastic pollution and carbon emissions associated with plastic production. Significant research in the use of alternative materials such as corn starch, sugarcane, pectin, wheat bran, and others is widely observed.

The increasing number of new drug approvals, increasing healthcare spending, and robust market for biopharmaceuticals and generics is encouraging the growth of the pharmaceutical packaging industry. A significant portion of companies is outsourcing their activities to focus on core operations.

With the drive towards sustainable materials, several contract organizations are building up smart and complex manufacturing capabilities.  Eco-friendly packs are widely marketed by leading contract organizations to attract pharmaceutical companies.

 

Pharmaceutical Contract Packaging Market Share Analysis- Primary Packaging held the largest market driven by bottles, vials, ampoules, blister packs, and others

Primary packaging is the most important packaging type in the pharmaceutical industry and the package components and subcomponents come in direct contact with the product. It ensures the product is preserved and adequate information is provided to the consumers and distributors. Also referred to as retail packaging or POS (Point-of-Sale) Packaging, it should be inert and should ensure no alteration is caused to the chemical composition.

The product-to-packaging material component stability and compatibility are often confirmed in the drug development stage. The primary packaging must preserve the physical properties of all dosage forms, protect them against damage or breakage, must not alter the identity of the product, preserve the characteristic properties of the product, and protect the product against undesirable or adulterating chemical, biological or physical entities, and others.

Accordingly, most small and medium-scale drug development companies rely on third-party specialized packaging service providers to ensure efficiency in product and cost. Different primary packaging types including bottles, vials, ampoules, blister packs, and others are analyzed in the report.

 

Disposable Endoscopy Market Segmentation

Types

• Primary Packaging
  • Bottles
  • Vials
  • Ampoules
  • Blister Packs
  • Others
• Secondary Packaging
• Tertiary Packaging

Materials

• Glass
• Plastics and Polymers
• Paper and Paperboard
• Metal
• Others

Regions

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Companies Profiled in the Research Study-

• Ropack Inc.
• UDG Healthcare Plc.
• Reed-Lane, Inc.
• AbbVie Contract Manufacturing
• PCI Pharma Services
• UNICEP Packaging LLC
• Ball Corp
• Amcor Plc
• Daito Pharmaceutical
• Patheon Pharma Services

1. Executive Summary

1.1 Introduction to Pharmaceutical Contract Packaging Markets

1.2 Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2030

1.3 Growth Opportunities in Pharmaceutical Contract Packaging Industry

1.4 Winning Strategies for the post-pandemic future

 

2. Report Guide

2.1 Market Definition and Scope

2.2 Market Segmentation

2.3 Research Methodology

2.4 Forecast Methodology

2.5 List of Abbreviations

 

3. Growth Opportunity Analysis

3.1 Key Pharmaceutical Contract Packaging Market Trends

3.1.1 Increasing demand for sustainable packaging

3.1.2 Demand for parenteral containers

3.1.3 Evolution of advanced technologies including nanotechnology

 

3.2 Key Pharmaceutical Contract Packaging Market Growth Drivers

3.2.1 Growth in the geriatric population

3.2.2 Increasing global Healthcare Expenditure worldwide

 

3.3 Key Pharmaceutical Contract Packaging Market Growth Restraints

3.3.1 Adherence to stringent regulatory standards across countries

3.3.2 Fragmented market conditions

3.3.3 Stringent government regulations

 

4 Pharmaceutical Contract Packaging Market Outlook – Scenario Analysis

4.1 Low Growth Case Scenario Forecasts: Pharmaceutical Contract Packaging Market Size Outlook to 2030

4.2 Reference Growth Case Scenario Forecasts: Pharmaceutical Contract Packaging Market Size Outlook to 2030

4.3 High Growth Case Scenario Forecasts: Pharmaceutical Contract Packaging Market Size Outlook to 2030

 

5. Pharmaceutical Contract Packaging Market Segmentation- Outlook by Type

5.1 Pharmaceutical Contract Packaging Market Share Analysis by Type, 2023

5.2 Market Outlook to 2030

5.3 Market Outlook to 2030

 

6. Pharmaceutical Contract Packaging Market Segmentation- Outlook by Type

6.1 Pharmaceutical Contract Packaging Market Share Analysis by Type, 2023

6.2 Primary Packaging Market Outlook to 2030

6.2.1 Bottles

6.2.2 Vials

6.2.3 Ampoules

6.2.4 Blister Packs

6.2.5 Other Primary Packaging Types

6.3 Secondary Packaging Market Outlook to 2030

6.4 Tertiary Packaging Market Outlook to 2030

 

7. Pharmaceutical Contract Packaging Market Segmentation- Outlook by Material

7.1 Pharmaceutical Contract Packaging Market Share Analysis by Material, 2023

7.2 Glass Pharmaceutical Contract Packaging Market Outlook to 2030

7.3 Plastic and Polymers Pharmaceutical Contract Packaging Market Outlook to 2030

7.4 Paper and Paperboard Pharmaceutical Contract Packaging Market Outlook to 2030

7.5 Metal Pharmaceutical Contract Packaging Market Outlook to 2030

7.6 Other Materials Pharmaceutical Contract Packaging Market Outlook to 2030

 

8. North America Pharmaceutical Contract Packaging Market Outlook and Opportunities to 2030

8.1 Market Snapshot, 2023

8.2 North America Pharmaceutical Contract Packaging Market Growth Opportunities

8.2.1 North America Pharmaceutical Contract Packaging Market Outlook by Type, 2021 to 2030

8.2.2 North America Pharmaceutical Contract Packaging Market Outlook by Material, 2021 to 2030

8.2.3 North America Pharmaceutical Contract Packaging Market Outlook by Country, 2021 to 2030

8.3 United States Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

8.4 Canada Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

8.5 Mexico Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

 

9. Europe Pharmaceutical Contract Packaging Market Outlook and Opportunities to 2030

9.1 Market Snapshot, 2023

9.2 Europe Pharmaceutical Contract Packaging Market Growth Opportunities

9.2.1 Europe Pharmaceutical Contract Packaging Market Outlook by Type, 2021 to 2030

9.2.2 Europe Pharmaceutical Contract Packaging Market Outlook by Material, 2021 to 2030

9.2.3 Europe Pharmaceutical Contract Packaging Market Outlook by Country, 2021 to 2030

9.3 Germany Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

9.4 France Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

9.5 United Kingdom Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

9.6 Spain Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

9.7 Italy Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

9.8 Other Europe Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

 

10. Asia Pacific Pharmaceutical Contract Packaging Market Outlook and Opportunities to 2030

10.1 Market Snapshot, 2023

10.2 Asia Pacific Pharmaceutical Contract Packaging Market Growth Opportunities

10.2.1 Asia Pacific Pharmaceutical Contract Packaging Market Outlook by Type, 2021 to 2030

10.2.2 Asia Pacific Pharmaceutical Contract Packaging Market Outlook by Material, 2021 to 2030

10.2.3 Asia Pacific Pharmaceutical Contract Packaging Market Outlook by Country, 2021 to 2030

10.3 China Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

10.4 Japan Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

10.5 India Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

10.6 South Korea Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

10.7 Indonesia Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

10.8 Other Asia Pacific Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

 

11. South and Central America Pharmaceutical Contract Packaging Market Outlook and Opportunities to 2030

11.1 Market Snapshot, 2023

11.2 South and Central America Pharmaceutical Contract Packaging Market Growth Opportunities

11.2.1 South and Central America Pharmaceutical Contract Packaging Market Outlook by Type, 2021 to 2030

11.2.2 South and Central America Pharmaceutical Contract Packaging Market Outlook by Material, 2021 to 2030

11.2.3 South and Central America Pharmaceutical Contract Packaging Market Outlook by Country, 2021 to 2030

11.3 Brazil Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

11.4 Argentina Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

11.5 Other Latin America Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

 

12. Middle East and Africa Pharmaceutical Contract Packaging Market Outlook and Opportunities to 2030

12.1 Market Snapshot, 2023

12.2 Middle East and Africa Pharmaceutical Contract Packaging Market Growth Opportunities

12.2.1 Middle East and Africa Pharmaceutical Contract Packaging Market Outlook by Type, 2021 to 2030

12.2.2 Middle East and Africa Pharmaceutical Contract Packaging Market Outlook by Material, 2021 to 2030

12.2.3 Middle East and Africa Pharmaceutical Contract Packaging Market Outlook by Country, 2021 to 2030

12.3 Saudi Arabia Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

12.4 United Arab Emirates (the UAE) Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

12.5 Other Middle East Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

12.6 Egypt Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

12.7 South Africa Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

12.8 Other Africa Pharmaceutical Contract Packaging Market Outlook, 2021 to 2030

 

13. Profiles of major world Pharmaceutical Contract Packaging Companies

13.1 Ropack Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.2 UDG Healthcare Plc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.3 Reed-Lane, Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.4 AbbVie Contract Manufacturing

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.5 PCI Pharma Services

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.6 UNICEP Packaging LLC

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.7 Ball Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.8 Amcor Plc

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

13.9 Daito Pharmaceutical

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

13.10 Patheon Pharma Services

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

 

14. Appendix

14.1 Publisher’s Expertise

14.2 List of Tables and Charts

14.3 List of Exhibits

14.4 Legal Disclaimer                     

Sample Request